#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13338	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2014	654.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	766	C	718	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13338	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2014	654.3	0	HET	.	.	.	C518T	.	518	518	C	750	750	C	790	C,T	566,174	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24316	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3612	670.8	0	.	n	.	0	T695C	SNP	695	695	T	1015	1015	C	761	C,T,A	723,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24316	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3612	670.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2291	2291	C	767	C,T	716,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24316	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3612	670.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2917	2917	T	789	T,C	581,164	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24316	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3612	670.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2365	2365	A	755	A	716	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1954	folP	852	852	100.0	folP.l15.c4.ctg.1	1562	124.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1020	1022	AGC	207;208;207	A;G;C	190;191;189	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5322	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3308	160.2	1	SNP	p	S91F	0	.	.	271	273	TCC	532	534	TCC	166;167;168	T;C;C,A	152;156;157,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5322	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3308	160.2	1	SNP	p	D95N	0	.	.	283	285	GAC	544	546	GAC	168;167;167	G,T,A;A;C,A	152,1,1;152;152,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5322	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3308	160.2	1	SNP	p	D95G	0	.	.	283	285	GAC	544	546	GAC	168;167;167	G,T,A;A;C,A	152,1,1;152;152,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1540	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1360	112.4	1	SNP	p	G45D	1	.	.	133	135	GAC	512	514	GAC	208;210;211	G;A,G;C	196;196,1;197	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	824	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1033	79.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.7	1	SNP	p	D86N	0	.	.	256	258	GAC	626	628	GAC	208;209;207	G;A;C	189;189;188	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.7	1	SNP	p	S87R	0	.	.	259	261	AGT	629	631	AGT	208;207;209	A;G;T	188;187;189	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.7	1	SNP	p	S87I	0	.	.	259	261	AGT	629	631	AGT	208;207;209	A;G;T	188;187;189	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.7	1	SNP	p	S87W	0	.	.	259	261	AGT	629	631	AGT	208;207;209	A;G;T	188;187;189	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4786	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2998	158.7	1	SNP	p	S88P	0	.	.	262	264	TCC	632	634	TCC	207;208;208	T;C;C,T	187;187;186,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4036	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2634	152.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1536	1538	GGC	211;208;208	G;G;C,T	197;193;191,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1267	1269	GCA	177;177;178	G;C;A	167;167;171	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1270	1272	ATC	178;178;176	A;T;C	171;169;167	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1282	1284	GTG	180;180;183	G;T,G;G	169;166,1;171	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1282	1284	GTG	180;180;183	G;T,G;G	169;166,1;171	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1786	1788	ACC	182;180;181	A;C;C	166;170;175	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1840	1842	GCG	168;166;166	G;C;G	147;132;139	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1840	1842	GCG	168;166;166	G;C;G	147;132;139	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1963	1965	GGC	152;153;153	G;G;C	140;139;138	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1972	1974	GGC	153;152;152	G;G;C	139;137;138	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3550	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2435	145.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1990	1992	CCG	139;138;141	C,G;C;G,T	108,5;102;110,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5086	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	2918	173.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1529	1531	CTG	178;179;179	C;T;G	159;164;163	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2350	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1759	132.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	519	519	C	165	C	154	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2366	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1528	153.8	0	.	p	.	0	I45V	NONSYN	133	135	ATT	448	450	GTT	193;192;189	G;T;T	181;180;176	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2366	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1528	153.8	0	.	p	.	0	N121S	NONSYN	361	363	AAC	676	678	AGC	181;181;180	A;G;C	171;171;170	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2366	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1528	153.8	0	.	p	.	0	N122K	NONSYN	364	366	AAC	679	681	AAA	181;180;176	A;A;A	172;171;169	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2366	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1528	153.8	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	742	744	GAA	198;199;199	G;A;A	186;186;185	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2366	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1528	153.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	766	768	GCA	202;200;203	G;C;A	190;191;193	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2366	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1528	153.8	0	.	p	.	0	K207_M208insK	INS	619	619	A	934	934	A	196	A	182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2366	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1528	153.8	0	.	p	.	0	A212S	NONSYN	634	636	GCA	952	954	TCA	192;195;194	T;C;A	182;186;186	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2366	porB1b	1038	1038	97.23	porB1b.l15.c17.ctg.1	1528	153.8	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1069	1069	T	177	T	170	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9012	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4803	187.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1962	1964	AAT	222;222;223	A;A;T	207;205;206	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	954	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1092	86.3	1	SNP	p	V57M	1	.	.	169	171	ATG	520	522	ATG	188;192;191	A;T;G	180;184;185	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
